You have 9 free searches left this month | for more free features.

RRMM-Relapsed or Refractory Multiple Myeloma

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 16, 2023

    Multiple Sclerosis Trial in Athens (Lifestyle intervention)

    Completed
    • Multiple Sclerosis
    • Lifestyle intervention
    • Athens, Greece
      Iaso Hospital
    Dec 14, 2021

    Acute Ischemic Stroke Trial in Cypress (LT3001 drug product, Placebo, Aspirin)

    Recruiting
    • Acute Ischemic Stroke
    • LT3001 drug product
    • +5 more
    • Cypress, California
      Lumosa Phase 1 Unit
    Mar 17, 2021

    Severe Asthma Trial in Belgium (Randomisation to omalizumab, Randomisation to mepolizumab)

    Recruiting
    • Severe Asthma
    • Randomisation to omalizumab
    • Randomisation to mepolizumab
    • Brussel, Brussels, Belgium
    • +12 more
    Nov 2, 2020

    Healthy Trial in Mannheim (BI 764198, Matching )

    Completed
    • Healthy
    • BI 764198
    • Matching placebo
    • Mannheim, Germany
      CRS Clinical Research Services Mannheim GmbH
    Nov 2, 2020

    Small Cell Lung Cancer Trial in Seoul (Olaparib)

    Completed
    • Small Cell Lung Cancer
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Feb 16, 2021

    Relapsing-Remitting Multiple Sclerosis Trial in Berlin (Prolonged Fasting, Ketogenic low glycemic load treatment, Control diet)

    Completed
    • Relapsing-Remitting Multiple Sclerosis
    • Prolonged Fasting
    • +2 more
    • Berlin, Germany
      Charité-Universitätsmedizin
    Apr 6, 2021

    Rheumatoid Arthritis (RA), Inflammatory Bowel Disease - IBD1 Trial in Guizhou (ZL-82 12.5mg, ZL-82 25mg, ZL-82 50mg)

    Recruiting
    • Rheumatoid Arthritis (RA)
    • Inflammatory Bowel Disease - IBD1
    • ZL-82 12.5mg
    • +7 more
    • Guizhou, GuiYang, China
      Affiliated Hospital of Guizhou Medical University
    Sep 19, 2023

    Functional Disorder Trial (Acceptance and Commitment Therapy)

    Completed
    • Functional Disorder
    • Acceptance and Commitment Therapy
    • (no location specified)
    Jun 9, 2021

    MDD Trial in Toronto (MR-guided Focused Ultrasound)

    Recruiting
    • Major Depressive Disorder
    • MR-guided Focused Ultrasound
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Mar 15, 2021

    Parkinson Disease Trial in Worldwide (ExAblate Pallidotomy, Sham ExAblate Pallidotomy)

    Active, not recruiting
    • Parkinson Disease
    • ExAblate Pallidotomy
    • Sham ExAblate Pallidotomy
    • Stanford, California
    • +19 more
    Nov 5, 2020

    Quality of Life AfterMultidisciplinary Auditory Rehabilitation

    Active, not recruiting
    • Acquired Deafness
      • Paris, France
        Hôpital Sainte-Marie
      Oct 31, 2022

      Idiopathic Pulmonary Fibrosis Trial in London (Morphine Sulfate, Placebo oral tablet)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • Morphine Sulfate
      • Placebo oral tablet
      • London, United Kingdom
        Royal Brompton Hospital
      May 25, 2022

      Liver Cirrhosis Trial in China (Rivaroxaban)

      Recruiting
      • Liver Cirrhosis
      • Guangzhou, Guangdong, China
      • +10 more
      Oct 22, 2022

      Endometrial Polyp Benign, Retained Products of Conception, Myoma;Uterus Trial in Genk, Leuven (Hysteroscopic morcellation 19 Fr.

      Recruiting
      • Endometrial Polyp Benign
      • +2 more
      • Hysteroscopic morcellation 19 Fr. intrauterine BIGATTI Shaver for uterine intracavitary lesions
      • Genk, Belgium
      • +1 more
      Mar 30, 2023

      Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Best Practice, Ibrutinib, Patient Derived

      Unknown status
      • Recurrent Mantle Cell Lymphoma
      • Refractory Mantle Cell Lymphoma
      • Best Practice
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 23, 2020

      Trauma Specific Frailty Index

      Recruiting
      • Physical Trauma
      • Trauma Specific Frailty Index Questionnaire
      • Dallas, Texas
        Methodist Dallas Medical Center
      Dec 9, 2021

      Well-Being, Psychological Trial (Genetic)

      Not yet recruiting
      • Well-Being, Psychological
      • Genetic
      • (no location specified)
      Sep 14, 2023

      Burns, Infection Wound, Bacterial Infections Trial in Lubbock (Open-to-air strategy, Traditional closed-wound management)

      Withdrawn
      • Burns
      • +2 more
      • Open-to-air strategy
      • Traditional closed-wound management
      • Lubbock, Texas
        Texas Tech University Health Sciences Center
      Dec 14, 2021

      Obsessive Compulsive Disorder (OCD) Trial in New York (Selective focal stimulation of ALIC-pathways)

      Recruiting
      • Obsessive Compulsive Disorder (OCD)
      • Selective focal stimulation of ALIC-pathways
      • New York, New York
        Mount Sinai West
      Jan 4, 2022

      Multiple Sclerosis and Voiding Symptoms: How to Assess?

      Completed
      • Multiple Sclerosis
      • +2 more
      • voiding phase evaluation
      • Paris, France
        Department of Neuro- Urology, Hôpital Tenon
      Jun 18, 2021

      Multiple Myeloma, Minimal Residual Disease, High-Risk Cancer Trial in New York (WT1 Analog Peptide Vaccine, Sargramostim

      Unknown status
      • Multiple Myeloma
      • +2 more
      • WT1 Analog Peptide Vaccine
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 6, 2020

      Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis Trial in United States

      Recruiting
      • Eosinophilic Granulomatosis With Polyangiitis (EGPA)
      • +6 more
      • Naltrexone Hydrochloride
      • Placebo Comparator
      • Boston, Massachusetts
      • +6 more
      Jan 25, 2022

      B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia Trial in United States (AVL-292)

      Completed
      • B Cell Non-Hodgkin's Lymphoma
      • +2 more
      • Huntsville, Alabama
      • +12 more
      Nov 6, 2019

      Tumors, CNS, Pediatric Brain Tumor, Malignant Brain Tumor Trial in China (Tumour resection)

      Completed
      • Tumors, Central Nervous System
      • +3 more
      • Tumour resection
      • Hefei, Anhui, China
      • +37 more
      Aug 31, 2021